NCT00873223 - Examination of the Effects of Liraglutide on the Mode of Action of Insulin Detemir | Biotech Hunter

Enrollment

33

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions

DiabetesDiabetes Mellitus, Type 2

Interventions

DRUG

liraglutide

Subjects will self-inject liraglutide subcutaneously daily during the trial and three euglycemic clamps will be performed: one without liraglutide (insulin detemir alone), the second with only liraglutide treatment and the third with liraglutide and insulin detemir administration

DRUG

insulin detemir

Subjects will self-inject liraglutide subcutaneously daily during the trial and three euglycemic clamps will be performed: one without liraglutide (insulin detemir alone), the second with only liraglutide treatment and the third with liraglutide and insulin detemir administration

Trial Locations (1)

91911

Novo Nordisk Investigational Site, Chula Vista